State Rx Programs May Not Steer Patients To Preferred Medicare Plan – CMS
Executive Summary
State pharmaceutical assistance programs may not steer Medicare beneficiaries into preferred Part D drug plans, the final Medicare rule states
You may also be interested in...
Medicare Rx Premium Beats Projections Due To “Robust Competition”
The Centers for Medicare & Medicaid Services is playing up Part D premium levels as a sign that healthy competition among drug plans will help the program suit the pocketbooks of both beneficiaries and the federal government
Medicare Rx Premium Beats Projections Due To “Robust Competition”
The Centers for Medicare & Medicaid Services is playing up Part D premium levels as a sign that healthy competition among drug plans will help the program suit the pocketbooks of both beneficiaries and the federal government
State Rx Assistance Programs Should Contract With Part D Plans, CMS Says
The Centers for Medicare & Medicaid Services is encouraging state pharmaceutical assistance programs to pay Medicare prescription drug plans a risk-based per capita lump sum to provide wrap-around coverage for low-income beneficiaries